Gastrointestinal cancer: Which way is forward in the treatment of rectal cancer?

R.L. Jansen, G.L. Beets*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

Preoperative 5-fluorouracil-based chemoradiation with optimal surgery provides very effective local control in locally advanced rectal cancer. Does adding oxaliplatin as a radiosensitizer provide any additional benefit? Is more always better? Jansen, R. L. H. & Beets, G. L. Nat. Rev. Clin. Oncol. 10, 12-13 (2013); published online 11 December 2012; doi:10.1038/nrclinonc.2012.217

Original languageEnglish
Pages (from-to)12-13
Number of pages2
JournalNature Reviews Clinical Oncology
Volume10
Issue number1
DOIs
Publication statusPublished - 1 Jan 2013

Keywords

  • PHASE-III TRIAL
  • CHEMORADIATION
  • CHEMORADIOTHERAPY
  • OXALIPLATIN

Fingerprint

Dive into the research topics of 'Gastrointestinal cancer: Which way is forward in the treatment of rectal cancer?'. Together they form a unique fingerprint.

Cite this